About
curasan AG is a German medical technology company based in Frankfurt am Main, specializing in biomaterials for bone and tissue regeneration. Founded in 1988, curasan is recognized as a leader in regenerative medicine, serving markets in dental, orthopedic, trauma, and spinal surgery globally. The company offers a wide range of innovative products under the CERASORB® brand, including synthetic bone graft materials like β-tricalcium phosphate granules, pastes, foams, and cements. These products are designed to mimic human bone and support tissue regeneration. Additional product lines, such as OSBONE® and OSGIDE®, provide non-organic materials in various forms, enhancing the company's offerings. curasan's products are certified by international authorities, including the US FDA, and are available in over 50 countries. curasan maintains high-tech research, development, and manufacturing facilities, along with a subsidiary in Wake Forest, North Carolina. The company is committed to advancing research through its spin-off novaxomx, which focuses on growth factors to enhance healing. With over 2 million units of CERASORB® used worldwide, curasan AG plays a significant role in improving patient outcomes in surgical procedures.
Technologies
Keywords
Company Information
-
Employees 31
-
Founded 1988
-
Annual Revenue $6956000
Location
18 Ernst-Wiss-Strasse, Frankfurt, Hesse, Germany, 65933
